Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients. Issue 3 (14th February 2022)
- Record Type:
- Journal Article
- Title:
- Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients. Issue 3 (14th February 2022)
- Main Title:
- Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients
- Authors:
- Andrews, Laura
Goldin, Laurel
Shen, Yan
Korwek, Kimberly
Kleja, Kacie
Poland, Russell E.
Guy, Jeffrey
Sands, Kenneth E.
Perlin, Jonathan B. - Abstract:
- Abstract: Background: Statins are a commonly used class of drugs, and reports have suggested that their use may affect COVID‐19 disease severity and mortality risk. Objective: The purpose of this analysis was to determine the effect of discontinuation of previous atorvastatin therapy in patients hospitalized for COVID‐19 on the risk of mortality and ventilation. Methods: Data from 146, 413 hospitalized COVID‐19 patients were classified according to statin therapy. Home + in hospital atorvastatin use (continuation of therapy); home + no in hospital atorvastatin use (discontinuation of therapy); no home + no in hospital atorvastatin use (no statins). Logistic regression was performed to assess the association between atorvastatin administration and either mortality or use of mechanical ventilation during the encounter. Results: Continuous use of atorvastatin (home and in hospital) was associated with a 35% reduction in the odds of mortality compared to patients who received atorvastatin at home but not in hospital (odds ratio [OR]: 0.65, 95% confidence interval [CI]: 0.59–0.72, p < .001). Similarly, the odds of ventilation were lower with continuous atorvastatin therapy (OR: 0.70, 95% CI: 0.64–0.77, p < .001). Conclusions: Discontinuation of previous atorvastatin therapy is associated with worse outcomes for COVID‐19 patients. Providers should consider maintaining existing statin therapy for patients with known or suspected previous use. Abstract :
- Is Part Of:
- Journal of hospital medicine. Volume 17:Issue 3(2022)
- Journal:
- Journal of hospital medicine
- Issue:
- Volume 17:Issue 3(2022)
- Issue Display:
- Volume 17, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 17
- Issue:
- 3
- Issue Sort Value:
- 2022-0017-0003-0000
- Page Start:
- 169
- Page End:
- 175
- Publication Date:
- 2022-02-14
- Subjects:
- Hospital care -- Periodicals
Clinical medicine -- Periodicals
610 - Journal URLs:
- http://www3.interscience.wiley.com/cgi-bin/jtoc/111081937 ↗
https://www.journalofhospitalmedicine.com/jhospmed/issues ↗
https://shmpublications.onlinelibrary.wiley.com/journal/15535606 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jhm.12789 ↗
- Languages:
- English
- ISSNs:
- 1553-5592
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5003.298000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26139.xml